Literature DB >> 32010601

The Role of Endoscopic Ultrasound and Endoscopic Resection for Gastric Glomus: A Case Series and Literature Review.

Jinlong Hu1, Nan Ge1, Sheng Wang1, Xiang Liu1, Jintao Guo1, Guoxin Wang1, Siyu Sun1.   

Abstract

BACKGROUND AND OBJECTIVES: Preoperative diagnosis of gastric glomus tumor is very difficult, and there are few reports regarding the endoscopic treatment of glomus tumor of the stomach. Our aim is to provide a retrospective assessment of the imaging features of endoscopic ultrasound (EUS) and treatment of choice of gastric glomus tumor.
METHODS: A database of all patients with gastric glomus tumor who was treated at Shengjing Hospital of China Medical University between March 2011 and March 2017 was retrospectively analyzed. The EUS characteristics and patients' clinical data as well as their treatment were reviewed. At the same time, we compared EUS characteristics of gastric glomus tumor with that of gastrointestinal stromal tumor (GISTs), leiomyomas, schwannomas, and ectopic pancreas.
RESULTS: Eleven patients (3 male and 8 female patients) were included in the present study. The patients' age ranged from 37 to 62 years (mean age, 50.1 years). Ten patients received EUS examination. Eight lesions were presented with mild-hyperechoic round or oval mass; one lesion was mild-hyperechoic oval mass with hypoechoic spots; one lesion was hypoechoic oval mass. One patient received endoscopic full-thickness resection; 3 patients were treated by endoscopic submucosal dissection; and laparoscopic resection was performed for 7 patients.
CONCLUSIONS: Gastric glomus has typical EUS features to differentiate from other submucosal tumors. Compared with surgery, endoscopic resection is also a safe and effective treatment of choice for gastric glomus tumor.
© 2019 Jinlong Hu et al., published by Sciendo.

Entities:  

Keywords:  endoscopic full-thickness resection; endoscopic submucosal dissection; endoscopic ultrasound; glomus tumor

Year:  2019        PMID: 32010601      PMCID: PMC6985914          DOI: 10.2478/jtim-2019-0030

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


INTRODUCTION

Glomus tumor is a rare vascular tumor originating from glomus bodies. Although most of glomus tumors occur in the distal extremities, this can also occur in any part of body.[ In the gastrointestinal tract, glomus tumors are most commonly located in the stomach and present as submucosal tumors.[ Although glomus tumors are generally benign in nature, several malignant cases have been reported.[ Most of the gastric glomus tumors are asymptomatic and are incidentally discovered; sometimes it may present with gastrointestinal hemorrhage and abdominal pain.[ Many glomus tumors of the stomach, however, are misdiagnosed as other mesenchymal tumors, such as gastrointestinal stromal tumors (GISTs) and leiomyomas. Therefore, it is of paramount importance to accurately preoperative diagnose gastric glomus tumors. Endoscopic ultrasound (EUS) is a useful imaging technique for diagnosing the gastric submucosal tumors,[ but only a few case reports have been published regarding the characteristics of gastric glomus tumors.[ Surgical resection is a curable treatment for gastric glomus tumor. With the development of endoscopic equipment, endoscopic methods, such as endoscopic submucosal dissection (ESD) and endoscopic full-thickness resection (EFTR), have been widely used for gastric submucosal tumors. However, there were few articles regarding endoscopic resection of gastric glomus tumors, which might be due to its vascular nature. Thus, our aim is to describe the typical EUS features and endoscopic resection of gastric glomus tumors.

PATIENTS AND METHODS

Patients

A database of all patients with gastric glomus tumor who were treated at Shengjing Hospital of China Medical University between March 2011 and March 2017 was retrospectively analyzed. At the same time, we reviewed the EUS characteristics of GISTs, leiomyomas, ectopic pancreas, and schwannomas in patients. The EUS characteristics and patients’ clinical data as well as their treatment were reviewed. The study was approved by the Ethics Committee of China Medical University and all the patients signed written informed consent.

Methods

Endoscopic ultrasound

All EUS procedures were performed with a linear scanning ultrasound endoscope. A single experienced endosonographer reviewed all the EUS images. The following features were recorded: location, the presence of mucosal ulceration, shape, original layer, echogenicity, the presence of marginal halos, cystic change, and calcification. At the same time, we compared EUS characteristics with that of GISTs, leiomyomas, schwannomas, and ectopic pancreas.

Treatment

ESD

All ESD procedures were performed with propofol sedation and continuous cardiorespiratory monitoring. ESD was performed as follows: the circumferential of the tumor was marked by argon plasma coagulation (APC), and then, a cushion was made by injection of a mixed solution consisting of 100-mL saline and 1-mL indigo carmine. After the mucosa incision was made, dissection of the tumor was made. The hemostasis was performed by electric cautery or APC.

EFTR

The peritumor gastric tissues were incised, and then, the tumor and peritumor gastric tissues were gradually resected in full thickness and electric cautery was used for hemostasis. Then, the tumor was completely removed. Metallic clips or over-the-scope clip was used to close the iatrogenic perforation.

Laparoscopic resection and surgical resection

Laparoscopic resection and surgical resection were performed as previously reported.

Postoperative follow-up

Patients were suggested for the follow-up at 1, 3, 6, and 12 months after resection and annually thereafter to observe the wound healing and any residual tumor or recurrence.

RESULTS

Clinical data of patients

The clinical data for 11 patients (3 male and 8 female patients) were included in the present study and were summarized in Table 1. The patients’ age ranged from 37 to 62 years (mean age, 50.1 years). Seven patients had epigastric discomfort, two patients had abdominal pain, one patient had abdominal distension, and one patient presented as upper gastrointestinal bleeding.
Table 1

The clinical data of 11 patients with gastric glomus tumor

No.Age/SexSymptomSize of tumor (mm)LocationEndoscopic appearanceEUS layerEUS appearance
138/maleAbdominal pain19Greater curvature of antrumSMTFourthMild-hyperechoic round mass
262/femaleAbdominal discomfort10Greater curvature of gastric bodySMTFourthMild-hyperechoic round mass
356/femaleAbdominal discomfort11Anterior wall of antrumSMTFourthHypoechoic oval mass
452/femaleAbdominal pain27Posterior wall of antrumSMTFourthMild-hyperechoic oval mass
559/femaleAbdominal discomfort27Posterior wall of antrumSMTFourthMild-hyperechoic round mass
648/femaleUGH35Gastric bodySMT with a ulcer on the surfaceThird, FourthMild-hyperechoic oval mass with hypoechoic spots
747/femaleAbdominal discomfort12Greater curvature of antrumSMTFourthMild-hyperechoic round mass
856/maleAbdominal distension28Greater curvature of antrumSMTFourthMild-hyperechoic oval mass
950/maleAbdominal discomfort27Greater curvature of antrumSMT--
1037/femaleAbdominal discomfort22Anterior wall of antrumSMTFourthMild-hyperechoic round mass
1146/femaleAbdominal discomfort20Greater curvature of antrumSMTFourthMild-hyperechoic round mass

SMT, submucosal tumor.

The characteristics of the lesion and EUS findings

Ten patients received EUS. The EUS characteristics of 10 patients with gastric glomus tumors was presented in Table 1. Nine lesions were located in antrum and two tumors were found in the gastric body. All the lesions presented as a submucosal tumor and one lesion had an ulcer on its surface (Figure 1), leading to hemorrhage. The maximum size of tumors ranged from 10 to 35 mm with mean size being 19 mm. Nine lesions were from fourth layer, and one lesion was from third and fourth layers. Eight lesions were presented with mild-hyperechoic round or oval mass (Figure 2); one lesion was mild-hyperechoic oval mass with hypoechoic spots; one lesion was hypoechoic oval mass with a clear border. Ten patients with gastric GISTs located in gastric antrum, 10 patients with gastric leiomyoma located in gastric antrum. 10 patients with gastric schwannoma located in gastric antrum, and 10 patients with gastric ectopic pancreas located in gastric antrum were randomly selected. The EUS features of gastric glomus tumors were compared with that of gastric GISTs, leiomyoma, schwannoma, and ectopic pancreas, as shown in Table 2. The typical EUS feature of gastric glomus tumor is a triad: antrum; round or oval; mild-hyperechoic lesion from fourth layer.
Figure 1

Gastric glomus lesion presenting as a submucosal tumor, with an ulcer on its surface

Figure 2

Gastric glomus lesions presented with mild-hyperechoic round or oval mass

Table 2

The EUS features of gastric glomus tumors were compared with those of gastric GISTs, leiomyoma, schwannoma, and ectopic pancreas

Tumor type (case number)Mean size (range), mmLayerShapeEchogenicityMarginal haloCystic changeCalcification
Glomus tumor (10)19(10–35)Nine lesions were from fourth layer; one lesion was from third, fourth layerTen lesions were round or oval shapeNine lesions were mild-hyperechoic; one lesion was hypoechoicNoOne lesion had cystic changeNo
GIST (10)18(12–42)Ten lesions were from fourth layerTen lesions were oval shapeHypoechoicNoNo3 lesions had calcification
Leiomyoma (10)14(10–36)Ten lesions were from fourth layerTen lesions were oval shapeHypoechoicNoNoNo
Schwannoma (10)18(12–25)Ten lesions were from fourth layerTen lesions were oval shapeHypoechoicFour lesions had marginal haloNoNo
Ectopic pancreas (10)13(8–23)Nine lesions were from third layer; one lesion was from third, fourth layerEight lesions were flat shape; two lesions were oval shapeMixed-echoicNoNoNo
The clinical data of 11 patients with gastric glomus tumor SMT, submucosal tumor. Gastric glomus lesion presenting as a submucosal tumor, with an ulcer on its surface Gastric glomus lesions presented with mild-hyperechoic round or oval mass The EUS features of gastric glomus tumors were compared with those of gastric GISTs, leiomyoma, schwannoma, and ectopic pancreas One patient received EFTR; three patients were treated by ESD, and laparoscopic resection was performed for seven patients. Complete resection was performed in all the patients. No complications, such as delayed perforation and hemorrhage, occurred in any patients. Nine patients had the pathology of glomus tumor; two patients had pathology of glomus tumor with uncertain malignant potential, as shown in Table 3.
Table 3

The treatment of 11 patients with glomus tumor of the stomach

NoTreatmentPatologyPostoperative bleedingPostoperative perforationRecurrenceFollow-up, month
1ESDGlomus tumorNoNoNo3
2ESDGlomus tumorNoNoNo62
3ESDGlomus tumorNoNoNo48
4EFTRGlomus tumorNoNoNo60
5LaparoscopyGlomus tumorNoNoNo61
6LaparoscopyGlomus tumor with uncertain malignant potentialNoNoNo18
7LaparoscopyGlomus tumorNoNoNo56
8LaparoscopyGlomus tumor with uncertain malignant potentialNoNoNo24
9LaparoscopyGlomus tumorNoNoNo32
10LaparoscopyGlomus tumorNoNoNo6
11LaparoscopyGlomus tumorNoNoNo12

ESD: endoscopic submucosal dissection; EFTR: endoscopic full-thickness resection.

The treatment of 11 patients with glomus tumor of the stomach ESD: endoscopic submucosal dissection; EFTR: endoscopic full-thickness resection.

Follow-up

No recurrence or metastases were found in all patients during the follow-up period at a median follow-up time of 32 months (range, 3–62 months).

DISSCUSSION

Gastric glomus tumors are rare with a significant female dominance.[ Most of the gastric glomus tumor are located in antrum.[ We got similar results as previously reported. Patients with gastric glomus tumor can present different symptoms, such as abdominal discomfort or pain, and gastric glomus tumor is one of rare causes of gastrointestinal hemorrhage.[ One patient (1/11) presented with upper gastrointestinal bleeding in our report. Preoperative diagnosis of gastric glomus tumor is the key point for the treatment. Glomus tumors, GISTs, schwannomas, and neuro-endocrine tumors, however, exhibit similar findings on computed tomography, making it difficult to differentiate glomus tumor from other tumors.[ Moreover, some cases of glomus tumor of the stomach do not show the typical characteristics on CT. With EUS being widely used,[ EUS is of great importance for differential diagnosis of gastric submucosal tumor. In our report, the typical EUS features of glomus tumor of the stomach can be listed as follows: the lesion is located in antrum; its shape is round or oval on EUS; it is a mild-hyperechoic lesion from fourth layer. Hu et al. reported that gastric glomus tumors were oval (n = 4) and round (n = 6) in shape.[ The mild-hyperechogenicity may be due to its vascular nature. Yan et al. reported that Doppler EUS showed a prominent vascular signal in gastric glomus tumor.[ The typical EUS features of glomus tumor of the stomach were described in some reports.[ Nine patients (9/11) were presented with typical EUS features. Two lesions did not have the typical EUS features. One lesion was hypoechoic and one lesion was from third and fourth layer. Compared with other common gastric submucosal tumor, such as GISTs, leiomyoma, ectopic pancreas, and schwannoma, the typical EUS features of glomus tumor of the stomach can make the differential diagnosis. Some gastric glomus tumor with atypical EUS features is still difficult to differentiate on EUS. EUS elastography and contrast-enhanced EUS can provide more information.[ In addition, endoscopic ultrasound guided fine needle aspiration (EUS-FNA) can help in diagnosis.[ Although glomus tumor is a vascular lesion, it is safe to perform EUS-FNA. No complications, such as bleeding, happen. Few reports had demonstrated that gastric glomus tumor could be diagnosed by EUS-FNA.[ Glomus tumors are mesenchymal tumors with malignant potential.[ Although most of glomus tumor of stomach are benign, some malignant cases have been reported. [ In our study, there were two patients diagnosed with glomus tumor with uncertain malignant potential. So resection is the only curative therapy with a favorable prognosis for benign glomus tumor. Traditionally, surgery is the first choice of treatment for gastric glomus tumor.[ Endoscopic resection, such as ESD and EFTR, are being increasingly used in treating gastric submucosal tumors.[ However, to the best of our knowledge, there is rare report that gastric glomus tumor was treated by endoscopic resection,[ which may be due to its rarity and its vascular nature. Four patients in our study were treated by ESD or EFTR, and there was no fatal bleeding. During the follow-up, there was no residual tumor and no recurrence.

CONCLUSIONS

The typical EUS feature of glomus tumor of the stomach is that a round or an oval mild-hyperechoic lesion originating from fourth layer is located in antrum. Endoscopic resection is a safe and effective treatment of choice for gastric glomus tumor.
  49 in total

1.  Endoscopic ultrasound-guided fine needle aspiration as a diagnostic tool for gastric glomus tumours.

Authors:  Jordan Jones; Adam Cichowitz; Gary L Crosthwaite
Journal:  ANZ J Surg       Date:  2012 Jan-Feb       Impact factor: 1.872

2.  Computed tomography and clinical characteristics of gastric glomus tumors.

Authors:  Shu Dong Hu; Duan Min Hu; Wei Huang; Ke Min Chen; Qi Song
Journal:  J Dig Dis       Date:  2014-09       Impact factor: 2.325

3.  Endoscopic puncture-suture device to close gastric wall defects after full-thickness resection: a porcine study.

Authors:  Jintao Guo; Beibei Sun; Siyu Sun; Xiang Liu; Sheng Wang; Nan Ge; Guoxin Wang; Wen Liu
Journal:  Gastrointest Endosc       Date:  2016-06-27       Impact factor: 9.427

4.  Complete defect closure of gastric submucosal tumors with purse-string sutures.

Authors:  Yin Zhang; Xiang Wang; Guanying Xiong; Yun Qian; Honggang Wang; Li Liu; Lin Miao; Zhining Fan
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

5.  Glomus tumor: a clinicopathologic and electron microscopic study.

Authors:  M Tsuneyoshi; M Enjoji
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

6.  [Application of endoscopic full-thickness resection in the treatment of gastric tumors originated from
the muscularis propria].

Authors:  Xiangqi Liao; Anliu Tang; Dinghua Xiao; Shourong Shen; Yunxiang Yuan; Xiaoyan Wang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2016-03-28

7.  Contrast-enhanced ultrasound of small focal solid pancreatic lesions: A must!

Authors:  Christoph F Dietrich; Eike Burmester
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628

8.  Gastric Glomus Tumor: An Uncommon Source for an Acute Upper GI Bleed.

Authors:  Douglas Morte; Jason Bingham; Vance Sohn
Journal:  Case Rep Gastrointest Med       Date:  2018-05-13

9.  EUS-FNA using 22G nitinol or ProCore needles without on-site cytopathology.

Authors:  Charing Ching Ning Chong; Anthony Yuen Bun Teoh; Raymond Shing Yan Tang; Anthony Wing Hung Chan; Enders Kwok Wai Ng; Paul Bo San Lai
Journal:  Endosc Ultrasound       Date:  2018 Jan-Feb       Impact factor: 5.628

10.  EUS of an atypical ectopic pancreas.

Authors:  Alexander Flores; Charilaos Papafragkakis; Angad S Uberoi; Sayam Thaiudom; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

View more
  3 in total

1.  Prognostic significance of KIF23 expression in gastric cancer.

Authors:  Wei-Tian Liang; Xiao-Fang Liu; Hai-Bo Huang; Zi-Ming Gao; Kai Li
Journal:  World J Gastrointest Oncol       Date:  2020-10-15

2.  Endoscopic ultrasound-measured muscular thickness of the lower esophageal sphincter and long-term prognosis after peroral endoscopic myotomy for achalasia.

Authors:  Ye Liao; Ting-Yue Xiao; Yu-Fan Wu; Jing-Jing Zhang; Bao-Zhen Zhang; Yi-Dan Wang; Sheng Wang; Xiang Liu; Si-Yu Sun; Jin-Tao Guo
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

3.  Endoscopic full-thickness resection using an over-the-scope device: A prospective study.

Authors:  Jin-Tao Guo; Jing-Jing Zhang; Yu-Fan Wu; Ye Liao; Yi-Dan Wang; Bao-Zhen Zhang; Sheng Wang; Si-Yu Sun
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.